The National Biopharmaceutical Facility (NBF) at King Mongkut’s University of Technology Thonburi was established in 2008 through a collaboration between KMUTT and BIOTEC, NSTDA. As a cutting edge facility, NBF supports translational research and pilot-scale biologics production for Phase I and II clinical trials. With state-of-the-art production, R&D, and characterization labs, NBF strengthens Thailand’s biopharmaceutical capabilities, enhancing national competitiveness and preparedness for pandemics and health emergencies.